Pfizer

By Dave Muoio 03:43 pm October 9, 2019
Patient engagement has long been a tough nut for healthcare to crack, and it’s not for a lack of trying. New technologies that meet the patient in their home offer a clear opportunity to meet patients throughout the course of their daily lives, but the tools themselves are only half of the solution — making a real connection is just as much about addressing and responding to each individual’s...
By Laura Lovett 01:50 pm July 3, 2019
Diving deeper into digital, this quarter the pharma giants have continued to implement new tools to enhance clinical trials, support medication management with technology and partner in developing digital therapeutics.  Onc, a foreign entity to this established industry, pharma executives are now becoming better versed in working with digital health companies and sharing the lessons they've...
By Dave Muoio 10:03 am May 21, 2019
This morning Verily announced a series of new strategic partnerships with four global pharmaceutical companies that will bring low-burden digital data collection and analysis tools to clinical research projects. Alongside Novartis, Otsuka, Pfizer and Sanofi, the Alphabet subsidiary will employ its Project Baseline platform to increase the number and diversity of study populations by making it...
By Dave Muoio 12:00 pm April 9, 2019
Concerto HealthAI, the maker of a clinical insight generation platform that employs real-world data in its analyses, is racking up the pharma partnerships as of late. Just weeks after the artificial intelligence company agreed to a multi-year deal with Bristol-Myers Squibb, Concerto announced this morning a similar project with Pfizer that will support the latter’s research on precision oncology...
By Laura Lovett 11:12 am February 20, 2019
Looking to innovate in the research space, pharma giant Pfizer inked a deal with Ochsner Health System, a Louisiana academic healthcare system, to develop digital tools for clinical trials. The partners will be using Ochsner’s innovation lab, innovationOchsner, and Ochsner Research.  The multi-year strategic alliance revolves around a goal of improving “access and connectivity to clinical trials...
By MobiHealthNews 11:25 am December 26, 2018
The pharma industry has become increasingly interested in the digital health space over the last few years, but this quarter numerous projects that have been in the works for years have finally came to fruition. For instance, Pear's reSET, the first digital therapeutic cleared by the FDA, was recently launched to commercial markets.  But that wasn’t the only advance in the space as pharma...

Credit: jianke.com

By Dean Koh 09:51 pm November 29, 2018
Jianke.com, China's online healthcare platform, yesterday announced during the Jianke Doctor Rebrand & 2018 Jianke Partners' Conference in Shanghai that they will be entering into a strategic partnership with US-based global pharmaceutical leader Pfizer. Both companies will leverage their leadership in their respective fields and successful practices to implement a patient-focused strategy in...
By Dave Muoio 12:26 pm October 11, 2018
Pfizer recently detailed a number of C-suite shakeups coming in the wake of its incoming CEO Albert Bourla. Perhaps most relevant to Mobi readers is the appointment of the company's first chief digital and technology officer, Lidia Fonseca. Currently the CIO and SVP at Quest Diagnostics, Fonseca has also held tenure at the Laboratory Corporation of America, Synarc Incorporated and Philips...
By Dave Muoio 08:46 am June 27, 2018
Pfizer has announced the three winning startups it has selected to participate in the second year of Pfizer Healthcare Hub: London, a foster program for innovative startups able to demonstrate clear benefits to patients or clinicians. Medopad, an app platform for patients to log and share data during clinical trials or care; Inhealthcare, a remote patient monitoring company; and Perfect Ward, an...

Dr. Daniel Karlin, Greg Plante, Dr. Stephen Wicks, Dr. Zachary Beattie, and Dr. Mahesh Fuldeore

By Jonah Comstock 02:11 pm June 8, 2018
Pharma companies are increasingly embracing the use of wearables and other connected devices to streamline and improve data collection in clinical trials. But for all the advantages these devices might have, there also challenges — especially when it comes to data standardization. This week at BIO 2018, Dr. Daniel Karlin, Pfizer’s head of clinical, informatics, regulatory strategy, digital...